Molecular physiology of amylin

Area of Science:

• Endocrinology
• Molecular Biology
• Metabolic Research

Background:

• Amylin is a 37-amino acid peptide hormone co-secreted with insulin by pancreatic beta cells.
• It is found in amyloid deposits in type 2 diabetes patients.
• Amylin shares structural and functional similarities with calcitonin and CGRP.

Purpose of the Study:

• To investigate the structural requirements for amylin's metabolic activity.
• To explore the relationship between amylin, calcitonin, and CGRP signaling.
• To elucidate the receptor mechanisms underlying amylin's effects on glucose metabolism.

Main Methods:

• Characterization of amylin's structure-activity relationship.
• Comparative analysis of amylin, calcitonin, and CGRP activities.
• Cloning and expression of variant calcitonin receptors.
• Investigation of signaling pathways, including adenylyl cyclase and cAMP.

Main Results:

• Amylin's glucose-lowering effect requires an intact disulfide bond and C-terminal amide.
• Amylin exhibits calcitonin-like bone activity and CGRP-like vascular activity.
• Teleost fish calcitonins are potent agonists for amylin's metabolic effects.
• Amylin and related peptides act on G protein-coupled receptors, often coupled to adenylyl cyclase.
• Amylin's skeletal muscle effects are largely mediated via cAMP pathway activation.

Conclusions:

• Amylin's metabolic functions are critically dependent on its specific molecular structure.
• Amylin, calcitonin, and CGRP represent a peptide family acting on related receptors.
• The cAMP pathway is a key mediator of amylin's actions in skeletal muscle.
• Understanding these mechanisms offers insights into type 2 diabetes and metabolic regulation.